Relay Therapeutics Inc (NASDAQ: RLAY) on Friday, soared 3.08% from the previous trading day, before settling in for the closing price of $7.79. Within the past 52 weeks, RLAY’s price has moved between $1.77 and $8.36.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -23.05%. The company achieved an average annual earnings per share of 26.63%. With a float of $130.41 million, this company’s outstanding shares have now reached $172.63 million.
Relay Therapeutics Inc (RLAY) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Relay Therapeutics Inc is 24.89%, while institutional ownership is 74.70%. The most recent insider transaction that took place on Nov 03 ’25, was worth 434,511. In this transaction President and CEO of this company sold 62,073 shares at a rate of $7.00, taking the stock ownership to the 703,215 shares. Before that another transaction happened on Oct 29 ’25, when Company’s insider sold 21,394 for $7.50, making the entire transaction worth $160,455. This insider now owns 337,469 shares in total.
Relay Therapeutics Inc (RLAY) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.45 earnings per share (EPS) for the period topping the consensus outlook (set at -0.55) by 0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.63% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.64% during the next five years compared to -23.05% drop over the previous five years of trading.
Relay Therapeutics Inc (NASDAQ: RLAY) Trading Performance Indicators
Relay Therapeutics Inc (RLAY) is currently performing well based on its current performance indicators. A quick ratio of 19.14 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 166.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.75, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.66 in one year’s time.
Technical Analysis of Relay Therapeutics Inc (RLAY)
The latest stats from [Relay Therapeutics Inc, RLAY] show that its last 5-days average volume of 2.71 million was superior to 2.14 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 52.21%.
During the past 100 days, Relay Therapeutics Inc’s (RLAY) raw stochastic average was set at 88.19%, which indicates a significant increase from 64.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.52 in the past 14 days, which was higher than the 0.35 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.91, while its 200-day Moving Average is $4.28. Now, the first resistance to watch is $8.58. This is followed by the second major resistance level at $9.14. The third major resistance level sits at $9.57. If the price goes on to break the first support level at $7.59, it is likely to go to the next support level at $7.16. The third support level lies at $6.60 if the price breaches the second support level.
Relay Therapeutics Inc (NASDAQ: RLAY) Key Stats
Market capitalization of the company is 1.39 billion based on 173,322K outstanding shares. Right now, sales total 10,010 K and income totals -337,710 K. The company made 680 K in profit during its latest quarter, and -70,380 K in sales during its previous quarter.
